Skip to main content
. 2016 Apr 27;82(1):238–248. doi: 10.1111/bcp.12938

Table 4.

Odds ratios (OR) and 95% confidence intervals (95% CI) of acute serious liver injury associated with different time of exposure of NSAIDs and paracetamol

DRUG Time of exposure No. (%) of cases No. (%) of controls OR (95% CI) OR Adg (95% CI) *
NIMESULIDE
<15 days 25 (13.97) 176 (9.94) 1.66 (1.03–2.68) 1.89 (1.12–3.20)
15–30 days 2 (1.12) 5 (0.28) 4.82 (0.92–25.34) 4.89 (0.80–30.00)
>30 days 3 (1.68) 3 (0.17) 16.05 (2.60–98.94) 12.55 (1.73–90.88)
ASA
<15 days 7 (3.93) 76 (4.30) 0.93 (0.42–2.08) 1.06 (0.45–2.50)
15–30 days 1 (0.56) 1 (0.06) 10.60 (0.66–169.75) 6.31 (0.37–106.38)
>30 days 22 (12.36) 173 (9.79) 1.40 (0.83–2.35) 1.66 (0.93–2.96)
KETOPROFEN
<15 days 18 (10.06) 173 (9.77) 0.94 (0.54–1.64) 1.05 (0.57–1.93)
15–30 days 1 (0.56) 2 (0.11) 4.97 (0.45–54.87) 6.55 (0.56–76.66)
>30 days 0 (0) 2 (0.11) NA NA
IBUPROFEN
<15 days 23 (12.85) 162 (9.16) 1.52 (0.92–2.50) 1.89 (1.09–3.26)
15–30 days 1 (0.56) 4 (0.23) 2.57 (0.29–23.05) 2.53 (0.26–24.69)
>30 days 1 (0.56) 3 (0.17) 3.46 (0.36–33.29) 2.58 (0.25–26.95)
DICLOFENAC
<15 days 10 (5.59) 74 (4.19) 1.42 (0.70–2.87) 1.35 (0.63–2.92)
15–30 days 1 (0.56) 3 (0.17) 3.47 (0.36–33.40) 4.23 (0.40–45.07)
>30 days 1 (0.56) 4 (0.23) 2.58 (0.29–23.13) 4.66 (0.49–44.15)
PARACETAMOL
<15 days 61 (34.08) 286 (16.16) 3.08 (2.14–4.43) 2.66 (1.83–3.88)
15–30 days 3 (1.68) 7 (0.40) 6.01 (1.51–23.89) 5.25 (1.21–22.82)
>30 days 5 (2.79) 6 (0.34) 14.78 (3.90–56.00) 18.36 (4.60–73.34)
*

See methods sections for details of adjustment